Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2026 08:15 ET | Source: Amplexd Therapeutics, Inc.

Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy

Amplexd launches Phase 2 trial of self-administered EGCg investigational therapy targeting hr-HPV cervical lesions in women with ASC-US and LSIL.